Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HIV Infections × Colposcopy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 20 Uterine Cervical Dysplasia 13 Papillomavirus Infections 7 Precancerous Conditions 4 Neoplasms 3 Squamous Intraepithelial Lesions 2 Atypical Squamous Cells of the Cervix 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Sexually Transmitted Diseases, Viral 1 Sexually Transmitted Diseases 1 Papilloma 1 Neoplasms, Squamous Cell 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Histologic Type 1 HIV Infections 1 Genital Diseases 1 Adenocarcinoma in Situ 1

Interventions

Doxorubicin 19 Vincristine 16 Cyclophosphamide 12 Zidovudine 11 Bleomycin 11 Etoposide 10 Rituximab 6 Interferon alpha-2 6 Cytarabine 6 Prednisone 5 Liposomes 5 Dexamethasone 5 sargramostim 4 Specimen Handling 4 Methotrexate 4 Magnetic Resonance Spectroscopy 4 Leucovorin 4 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Fluorouracil 4 Filgrastim 4 Biopsy 4 tecogalan 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Carmustine 3 interferon alfa-n1 2 fludarabine 2 cabozantinib 2 Watchful Waiting 2 Vaccines 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05074264 2025-11-10

CAMPO-101

University of California, San Francisco

Phase NA Active not recruiting

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡